StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma cash

Cash and short-term investments held at the end of each period.

Connect Biopharma's cash was $31.50M at Jun 30, 2026. For fiscal 2025 it was $44.30M, down 52.7% from the year before. The highest annual figure on record is $267.72M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.30M-52.7%
FY2024Dec 31, 2024$93.70M-20.8%
FY2023Dec 31, 2023$118.30M+49.9%
FY2022Dec 31, 2022$78.95M-70.5%
FY2021Dec 31, 2021$267.72M+72.9%
FY2020Dec 31, 2020$154.80M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$31.50M-56.1%
Q1 FY2026Mar 31, 2026$46.03M-45.2%
Q4 FY2025Dec 31, 2025$44.30M-52.7%
Q3 FY2025Sep 30, 2025$54.80M-43.6%
Q2 FY2025Jun 30, 2025$71.80M-34.6%
Q1 FY2025Mar 31, 2025$84.00M-26.4%
Q4 FY2024Dec 31, 2024$93.70M-20.8%
Q3 FY2024Sep 30, 2024$97.19M+19.1%
Q2 FY2024Jun 30, 2024$109.84M+39.1%
Q1 FY2024Mar 31, 2024$114.10M-19.3%
Q4 FY2023Dec 31, 2023$118.30M-55.8%
Q2 FY2023Jun 30, 2023$81.61M-47.3%
Q4 FY2022Dec 31, 2022$78.95M–
Q2 FY2022Jun 30, 2022$141.37M–
Q4 FY2021Dec 31, 2021$267.72M–
Q4 FY2020Dec 31, 2020$154.80M–

More Connect Biopharma figures

See a number that looks wrong?